Cargando…

Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators

Acute-on chronic liver failure (ACLF) is a syndrome that develops in patients with acutely decompensated cirrhosis (AD). It is characterized by a systemic hyperinflammatory state, leading to multiple organ failure. Our objective was to analyze macrophage anti-inflammatory protein CD5L in plasma extr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Rodríguez, María Belen, Téllez, Érica, Casulleras, Mireia, Borràs, Francesc E., Arroyo, Vicente, Clària, Joan, Sarrias, Maria-Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940329/ https://www.ncbi.nlm.nih.gov/pubmed/35330909 http://dx.doi.org/10.3389/fimmu.2022.842996

Ejemplares similares

Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure
por: Casulleras, Mireia, et al.
Publicado: (2020)

Albumin Lipidomics Reveals Meaningful Compositional Changes in Advanced Cirrhosis and Its Potential to Promote Inflammation Resolution
por: Casulleras, Mireia, et al.
Publicado: (2022)

Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
por: Basil, Maria C., et al.
Publicado: (2015)

Specialized Pro-Resolving Mediators and the Lymphatic System
por: Kraft, Jamie D., et al.
Publicado: (2021)

Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failure
por: Clària, Joan, et al.
Publicado: (2023)

Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
por: Philippe, Réginald, et al.
Publicado: (2018)

Role of Specialized Pro-Resolving Mediators in Neuropathic Pain
por: Leuti, Alessandro, et al.
Publicado: (2021)

The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
por: Torres, Wheeler, et al.
Publicado: (2023)

Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer’s Disease
por: de Wit, Nienke M., et al.
Publicado: (2021)

Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
por: Ferri, Giulia, et al.
Publicado: (2023)

The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
por: Sousa, Ana Beatriz, et al.
Publicado: (2023)

Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19
por: Balta, Maria G., et al.
Publicado: (2021)

The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease
por: Briottet, Maelle, et al.
Publicado: (2020)

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
por: Chávez-Castillo, Mervin, et al.
Publicado: (2021)

Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders
por: Ponce, Jana, et al.
Publicado: (2022)

Specialized pro-resolving lipid mediators in endodontics: a narrative review
por: Aubeux, Davy, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
por: Gila-Diaz, Andrea, et al.
Publicado: (2021)

Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease
por: Dalli, Jesmond, et al.
Publicado: (2022)

Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis
por: Rangarajan, Subhapradha, et al.
Publicado: (2022)

Small fragments of hyaluronan are increased in individuals with obesity and contribute to low-grade inflammation through TLR-mediated activation of innate immune cells
por: Romo, Mònica, et al.
Publicado: (2022)

Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury
por: Yin, Ping, et al.
Publicado: (2018)

Application of specialized pro‐resolving mediators in periodontitis and peri‐implantitis: a review
por: Ali, Muhanad, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling
por: Díaz del Campo, Lucía Serrano, et al.
Publicado: (2022)

Specialized Pro-Resolving Mediators Reduce Scarring After Cleft Lip Repair
por: Papathanasiou, Evangelos, et al.
Publicado: (2022)

Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications
por: Valente, Mariarosaria, et al.
Publicado: (2022)

Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections
por: Rasquel-Oliveira, Fernanda S., et al.
Publicado: (2023)

Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids
por: Artru, Florent, et al.
Publicado: (2022)

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
por: Fredman, Gabrielle, et al.
Publicado: (2016)

Low doses of LPS exacerbate the inflammatory response and trigger death on TLR3-primed human monocytes
por: Monguió-Tortajada, Marta, et al.
Publicado: (2018)

Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit
por: Flores-Costa, Roger, et al.
Publicado: (2020)

Stereoselective Synthesis and Structural Confirmation of the Specialized Pro-Resolving Mediator Resolvin E4
por: Reinertsen, Amalie Føreid, et al.
Publicado: (2021)

Role of Specialized Pro-Resolving Mediators in Modifying Host Defense and Decreasing Bacterial Virulence
por: Thornton, Julianne M., et al.
Publicado: (2021)

Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development
por: Yang, Ailin, et al.
Publicado: (2021)

Sex differences in specialized pro-resolving lipid mediators and their receptors in abdominal aortic aneurysms
por: Filiberto, Amanda C., et al.
Publicado: (2023)

Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine
por: Monguió-Tortajada, Marta, et al.
Publicado: (2017)

Extracellular Vesicles From Auditory Cells as Nanocarriers for Anti-inflammatory Drugs and Pro-resolving Mediators
por: Kalinec, Gilda M., et al.
Publicado: (2019)

Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples
por: Kutzner, Laura, et al.
Publicado: (2019)

Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction
por: Fosshaug, Linn E., et al.
Publicado: (2019)

Subgingival Microbiome and Specialized Pro-Resolving Lipid Mediator Pathway Profiles Are Correlated in Periodontal Inflammation
por: Lee, Chun-Teh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m4ljsd33ggpue01ug2b1kn1ln4